Update-3 ,,,11/22/24…11:11 EST... Might be another good day for Life Science stocks: ABBV MRK PFE etc. Added to Quidel/Ortho (QDEL) at 39 + with options after secondary offering. SMID caps are back with XBI crossing $95 level!. SMID ETFs are running too IWR, IJR etc.
2:37P 11/22…Green screen day in SMID and spec biotechs with XBI at $96+; CPRX,QDEL,SUPN,VCYT etc.
Bought BDSX at $1.50″ beaten up” life science stock like GH, TXG and QDEL
XBI up with SMID cap biotech rally.
=========
Update-2 2/21/24….2:33 EST..A good day for trading in a beaten up sector: ABB, BDX,BMY, ILMN,MRK, GILD, UNH.
Update-1 11/20/24 …Can UNH save the healthcare sector, up 4.08% to $600+. Large cap biopharmas show some gains: ABBV up 0.71%, AMGN up 2.83%, GILD up 1%,LLY +0.3.24%, MRK+0.93%,VRTX+0.71%. XLV up 1.18% to $142.88.
SMID caps: GEHC up 2.88%, NTRA up 3.57%, SUPN up 1.66%, VCEL up 2.56%,XBI up 0.84% to $94.
Bruker (BRKR) up 10% on $5M insider buy.
=========
Worse week for Healthcare Stocks. What you can do?
- Nothing wait just for volatility to settle down and look to other portfolio sectors to invest.
- Nibble on your favorite dividend paying large cap biopharma.Take tax losses on your losers.
- Look for other great health science stocks within MEDtech.
As we mentioned earlier this month large cap healthcare stocks were supposed to be relatively safe from market turmoil and macro news because of the large demographics and the priority individuals place on their health. But last week healthcare and biotech stocks got whipped badly by a constellation of bad news. First it began when a few of our best performers took a bashing like Abbvie and Eli Lilly. Then you layer on the FEDspeak where you layer on a some doubts about future rate cuts. Then came an assault from some potential TRUMP Cabinet picks offering ideas to revolutionize the health care system . We all know that uncertainty is not good for the market but that ‘s what we have despite all the positive factors coming through this election cycle.
The market was quiet today but we should still expect some gains through year -end albeit a bit choppy.. Here are some numbers from DAY One NOV 18: S&P 500 up 0.39% to 5823 , QQQ up 3.45% to 500, IBB down 0.25% to 133, XLV up 0.1% to $141.94, XBI up 0.13% to 91.96. So compare the numbers below for key biotech and healthcare ETFs and stocks. We should be able to hold these levels through year-end before new Administration healthcare policies and year end 2024 earnings reports and guidance come in January 2025.
NOTABLE MOVERS today were: ABBV up 0.78%. BMY up 1.03%, LLY down 2.5%. JNJ up 0.5% but flat for the past 5 days at $154.77. Otherwise not much and need a few more days to break downtrend.
MedTech looks better with less pricing politics. The U.S. Medical Device ETF (IHI) was up 0.89% to $60 level , flat over 5 days up 2.42% for the month, up 11.3% YTD. Medtronic reports tomorrow and pays a dividend of 3.2%. We also own ABT, ISRG and SYK.
SMID Life Science trades may be too volatile until biotech gets its Momentum back, Here are some positions that are holding up better: CRMD up 5.6% today at $10.91, NTRA up 6.04% at $153.42, TWST up 12.1% today at $41.4, and we still like VCEL and VCYT. And EXEL is holding near ts top up over 43% YTD.
Here are two interesting long term charts for the XLV and XBI. Note the post COVID biotech crash and recovery for XBI.
| 1/15/18 | 3/31/23 | 11/1/19 | 10/8/2023 | 2024 | YTD | FWD | Analyst | % | 5 d % | % | ||||
| Company | Ticker | Price | Price | Price | Price | PRICE | 1 mo. | trend ST | ||||||
| 11/16/24 | % Perf | P/S | PE | Recom | Div | |||||||||
| Abbvie | ABBV | 100.000 | 159.37 | 81.75 | 148.23 | 165 | 6.47 | 5.11 | 13.58 | 1.79 | 3.74 | -17.3 | -14 | gap u/d |
| Alexion*(ALXN) | ALXN | 123.000 | 182.5 | 109.38 | – | 40.33 | n/a | 4.56 | 9.38 | n/a | AZN | |||
| Amgen | AMGN | 185.000 | 241.75 | 221 | 263 | 283.61 | -1.53 | 4.52 | 13.69 | 2.29 | 3.21 | -12.81 | -12.76 | d |
| AstraZeneca* | AZN | 35.000 | 69.41 | 40.34 | 67.42 | 63.23 | -4.25 | 3.83 | 13.41 | 1.93 | 2.46 | 1.51 | -16.11 | gap d |
| Biogen | BIIB | 336.000 | 278.31 | 299.2 | 263.25 | 160 | -38.17 | 1.82 | 9.51 | 1.82 | – | -7.54 | -16.48 | low |
| Bristol Myers* | BMY | 63.000 | 69.31 | 57.16 | 56.66 | 56.22 | 9.57 | 2.31 | 7.98 | 2.8 | 4.25 | 3.84 | 6.56 | |
| Celgene* (BMY) | CELG | 106.000 | n/a | 108.53 | – | 77 | n/a | 4.69 | 8.7 | n/a | ||||
| Gilead Sci | GILD | 79.000 | 82.97 | 61.69 | 74.74 | 88.4 | 9.12 | 3.74 | 11.82 | 2.03 | 3.47 | -8.46 | 3.01 | high |
| GlaxoSmithK* | GSK | 38.000 | 35.58 | 45 | 36.65 | 33.35 | -10 | 1.71 | 7.71 | 2.5 | 4.66 | -8.1 | -14.4 | low |
| Johnson&J* | JNJ | new | 154.01 | -1.75 | 4.29 | 14.55 | 2.13 | 3.04 | -0.95 | -6.15 | ||||
| Eli Lilly | LLY | 85.000 | 343.42 | 113 | 565.22 | 746.2 | -28.01 | 16.45 | 33.13 | 1.58 | -0.73 | -10.26 | -18.3 | rsi low |
| Merck | MRK | 59.000 | 106.39 | 78 | 103.88 | 96.46 | -11.86 | 3.79 | 10.24 | 1.59 | 3.16 | -6.42 | -13.65 | low |
| Pfizer | PFE | 40.8 | 33.13 | 24.8 | -13.86 | 2.23 | 8.57 | 2.3 | 6.79 | -7.19 | -15.76 | rsi low | ||
| Regeneron | REGN | 367.000 | 821.67 | 310.48 | 836.57 | 756.81 | -13.83 | 5.81 | 16.75 | 1.77 | – | -8.64 | -25.55 | low |
| Vertex | VRTX | 158.000 | 315.07 | 196 | 360.62 | 465.7 | 14.45 | 10.87 | 27.46 | 1.97 | – | -9.88 | -3.84 | high |
| 3/31 | 11/19 | 10/7/23 | 11/16/24 |
%YTD
|
5 days % | 1 mo. | Trend | |||||||
| XBI | 76.21 | 93 | 72.23 | 91.83 | 2.84 | -11.85 | -7.53 | d | ||||||
| IBB | 129.16 | 119.65 | 122.48 | 133.38 | -1.82 | -10.39 | -8.53 | d | ||||||
| FBIOX | 15.63 | 20.26 | 15.47 | 19.61 | 9.98 | – | -9.55 | d | ||||||
| PRHSX | 87.75 | 79 | 86.37 | 92.58 | 5.32 | – | -7.37 | d | ||||||
| XLV | 129.46 | 121.11 | 128 | 141.84 | 5.46 | -5.55 | -7.2 | d | ||||||
| XPH | 41.01 | 39.47 | 39.05 | 45.05 | 8.24 | -6.24 | -2.57 | d | ||||||
| UNH | 472.59 | 252 | 524.81 | 592.23 | 12.49 | -3.83 | 6.46 | – | ||||||
| QQQ | 320.93 | 201.23 | 364.7 | 496.57 | 25.55 | -3.42 | 1.17 | – | ||||||
| iIHI | ? | 43 | 56.5 | 59.54 | 10.32 | -1 | 1.41 | -/u | ||||||